Secondary Logo

Institutional members access full text with Ovid®

Procurement strategies for combined multiorgan and composite tissues for transplantation

Datta, Néhaa; Yersiz, Hasanb; Kaldas, Fadyb; Azari, Kodia,c

Current Opinion in Organ Transplantation: April 2015 - Volume 20 - Issue 2 - p 121–126
doi: 10.1097/MOT.0000000000000172
Editor's Choice

Purpose of review The purpose of this article is to identify the unique aspects of combined multiorgan and vascularized composite allograft (VCA) procurement from deceased donors and outline the steps essential for success.

Recent findings Transplantation of nonsolid organ composite tissues is becoming a viable option for reconstruction of massive tissue defects. With the United Network for Organ Sharing designation of VCAs as organs, placing them under the domain of the Organ Procurement and Transplantation Network, a systematic method for combined solid organ and VCA procurement is required. Several centers have reported experience with successful procurement strategies including sequential and simultaneous retrievals. The published literature describing donor screening, sequence of procurement with relation to solid organs and allocation is reviewed.

Summary With the 2013 classification of VCAs as organs, the Organ Procurement and Transplantation Network and United Network for Organ Sharing are better suited to aligning procurement and allocation policies. As VCA transplantation becomes more commonplace, protocol guidelines will ensure smooth integration with existing procurement infrastructure.

aDepartment of Surgery, Section of Reconstructive Transplantation

bDepartment of Surgery, Dumont-UCLA Liver Cancer and Transplant Centers, Pfleger Liver Institute

cDepartment of Orthopedic Surgery, University of California, Los Angeles, California, USA

Correspondence to Kodi Azari, Surgical Director, Reconstructive Transplantation Program, Department of Surgery, University of California, Los Angeles, 10945 Le Conte Avenue, Room 3355G, Los Angeles, CA 90095, USA. Tel: +1 310 825 1745; e-mail:

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.